These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 34366663)
1. COVID-19: Vaccine Delivery System, Drug Repurposing and Application of Molecular Modeling Approach. Abd El Hadi SR; Zien El-Deen EE; Bahaa MM; Sadakah AA; Yassin HA Drug Des Devel Ther; 2021; 15():3313-3330. PubMed ID: 34366663 [TBL] [Abstract][Full Text] [Related]
2. Repurposing anticancer drugs for the management of COVID-19. El Bairi K; Trapani D; Petrillo A; Le Page C; Zbakh H; Daniele B; Belbaraka R; Curigliano G; Afqir S Eur J Cancer; 2020 Dec; 141():40-61. PubMed ID: 33125946 [TBL] [Abstract][Full Text] [Related]
3. Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight. Akilesh SM; J R; Palanisamy D; Wadhwani A Curr Pharm Biotechnol; 2021; 22(2):192-199. PubMed ID: 32867651 [TBL] [Abstract][Full Text] [Related]
4. Role of Novel Drug Delivery Systems in Coronavirus Disease-2019 (COVID-19): Time to Act Now. Mittal N; Garg V; Bhadada SK; Katare OP Curr Drug Deliv; 2021; 18(3):289-296. PubMed ID: 32938349 [TBL] [Abstract][Full Text] [Related]
5. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19. Rohilla S Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities. Delcuve GP; Lakowski TM; Su RC; Beacon TH; Davie JR IUBMB Life; 2020 Nov; 72(11):2313-2330. PubMed ID: 32918855 [TBL] [Abstract][Full Text] [Related]
7. Implication of nanotechnology-based approaches to combat SARS-CoV-2 infection. Heidari M; Salmanpour M; Tamaddon AM Indian J Pharmacol; 2021; 53(1):78-79. PubMed ID: 33976004 [No Abstract] [Full Text] [Related]
8. COVID-19: morphology and mechanism of the SARS-CoV-2, global outbreak, medication, vaccines and future of the virus. Bhattacharyya P; Das S; Aich S; Sarkar J Front Biosci (Elite Ed); 2021 Dec; 13(2):272-290. PubMed ID: 34937314 [TBL] [Abstract][Full Text] [Related]
9. COVID-19 Infection: Targeting Possibilities for Treatment. Haider T; Gour V; Pandey V; Kanwar IL; Tiwari R; Vishwakarma M; Bakshi AK; Sarkar A; Yadav R; Soni S; Soni V Crit Rev Ther Drug Carrier Syst; 2021; 38(3):75-115. PubMed ID: 34348019 [TBL] [Abstract][Full Text] [Related]
10. An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies. Tsang HF; Chan LWC; Cho WCS; Yu ACS; Yim AKY; Chan AKC; Ng LPW; Wong YKE; Pei XM; Li MJW; Wong SC Expert Rev Anti Infect Ther; 2021 Jul; 19(7):877-888. PubMed ID: 33306423 [TBL] [Abstract][Full Text] [Related]
11. Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2. Bilal M; Iqbal HMN Hum Vaccin Immunother; 2020 Dec; 16(12):3034-3042. PubMed ID: 32845742 [TBL] [Abstract][Full Text] [Related]
12. Fighting COVID-19 with Artificial Intelligence. Monteleone S; Kellici TF; Southey M; Bodkin MJ; Heifetz A Methods Mol Biol; 2022; 2390():103-112. PubMed ID: 34731465 [TBL] [Abstract][Full Text] [Related]
13. Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19. Tomazou M; Bourdakou MM; Minadakis G; Zachariou M; Oulas A; Karatzas E; Loizidou EM; Kakouri AC; Christodoulou CC; Savva K; Zanti M; Onisiforou A; Afxenti S; Richter J; Christodoulou CG; Kyprianou T; Kolios G; Dietis N; Spyrou GM Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34009288 [TBL] [Abstract][Full Text] [Related]
14. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity. Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P Cells; 2021 Oct; 10(11):. PubMed ID: 34831172 [TBL] [Abstract][Full Text] [Related]
15. Structure-based drug repurposing against COVID-19 and emerging infectious diseases: methods, resources and discoveries. Masoudi-Sobhanzadeh Y; Salemi A; Pourseif MM; Jafari B; Omidi Y; Masoudi-Nejad A Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33993214 [TBL] [Abstract][Full Text] [Related]
16. Drug Discovery of Small Molecules for the Treatment of COVID-19: A Review on Clinical Studies. Goel B; Bhardwaj N; Tripathi N; Jain SK Mini Rev Med Chem; 2021; 21(12):1431-1456. PubMed ID: 33371848 [TBL] [Abstract][Full Text] [Related]
17. A detailed review of the outbreak of COVID-19. Das K; Pingali MS; Paital B; Panda F; Pati SG; Singh A; Varadwaj PK; Samanta SK Front Biosci (Landmark Ed); 2021 May; 26(6):149-170. PubMed ID: 34162043 [TBL] [Abstract][Full Text] [Related]
18. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses. Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205 [TBL] [Abstract][Full Text] [Related]
19. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario. Gudadappanavar AM; Benni J J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964 [TBL] [Abstract][Full Text] [Related]